☆ 4.8 Letter

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain

JOURNAL OF HEPATOLOGY (2020)

Journal

JOURNAL OF HEPATOLOGY

Volume 73, Issue 5, Pages 1262-1263

Publisher

ELSEVIER

DOI: 10.1016/j.jhep.2020.07.007

Keywords

Funding

Instituto de Salud Carlos III (ISCIII) [PI18/00079]
Plan Estrategico Nacional contra la hepatitis C (Spanish Health Ministry)
Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement [2017_SGR_1753]
CERCA Programme/Generalitat de Catalunya
Asociacion Espanola para el Estudio del Higado (AEEH)

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain

Journal

JOURNAL OF HEPATOLOGY

Publisher

ELSEVIER

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain

Journal

JOURNAL OF HEPATOLOGY

Publisher

ELSEVIER

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper